A61K 2039/541
Mucosal route
Official title: {Mucosal route}
A61K2039/541 (Mucosal route) appears on 1,906 US grants and 3,177 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,906
- Published applications
- 3,177
- Assignees
- 1,451
- Inventors
- 5,595
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 4 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 5 | 0 |
| 1986 | 3 | 0 |
| 1987 | 6 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 6 | 0 |
| 1993 | 5 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 9 | 0 |
| 1997 | 24 | 0 |
| 1998 | 31 | 0 |
| 1999 | 29 | 0 |
| 2000 | 34 | 0 |
| 2001 | 23 | 12 |
| 2002 | 35 | 70 |
| 2003 | 32 | 79 |
| 2004 | 25 | 104 |
| 2005 | 29 | 96 |
| 2006 | 37 | 76 |
| 2007 | 29 | 70 |
| 2008 | 29 | 93 |
| 2009 | 39 | 109 |
| 2010 | 44 | 118 |
| 2011 | 52 | 139 |
| 2012 | 66 | 123 |
| 2013 | 67 | 114 |
| 2014 | 72 | 110 |
| 2015 | 76 | 112 |
| 2016 | 118 | 166 |
| 2017 | 116 | 177 |
| 2018 | 129 | 133 |
| 2019 | 105 | 162 |
| 2020 | 110 | 145 |
| 2021 | 99 | 138 |
| 2022 | 99 | 161 |
| 2023 | 73 | 170 |
| 2024 | 82 | 208 |
| 2025 | 82 | 176 |
| 2026 | 39 | 116 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Recombinant protein capable of resisting multiple sclerosis and preparation method and application thereof15 Sep 2026US 12,734,224 B2Institute of Zoology, Guangdong Academy of Sciences
- Compositions and methods for preventing and treating virus infection15 Sep 2026US 12,734,234 B2University of Virginia Patent Foundation
- Vaccine using M2/BM2-deficient influenza vectors8 Sep 2026US 12,728,160 B2FluGen, Inc.
- Immunogenic probiotic compositions and methods of use including in vaccination1 Sep 2026US 12,721,888 B2BiomEdit, Inc.
- Methods for preventing an immunoglobulin e-related disease25 Aug 2026US 12,714,736 B2My-Or Diagnostics Ltd.
- Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof8 Oct 2026US 2026/0306419 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Mucosal vaccines against tuberculosis8 Oct 2026US 2026/0306604 A1University of Houston System
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Pharmaceutical Composition for Vaccination against Cytomegalovirus Infections8 Oct 2026US 2026/0306606 A1Instar Technologies A.S.
- Method for inducing an immune response8 Oct 2026US 2026/0306617 A1Acclarent, Inc.
Most cited
By later US patents
- Method of potentiating an immune response425US 5,075,109 ASouthern Research Institute · 1991
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery242US 6,060,082 AMassachusetts Institute of Technology · 2000
- Receptor specific transepithelial transport of therapeutics240US 6,485,726 B1Brandeis University · 2002
- Receptor specific transepithelial transport of therapeutics214US 6,030,613 ABrandeis University · 2000